Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity.
Risom T, Wang X, Liang J, Zhang X, Pelz C, Campbell LG, Eng J, Chin K, Farrington C, Narla G, Langer EM, Sun XX, Su Y, Daniel CJ, Dai MS, Löhr CV, Sears RC.
Risom T, et al. Among authors: sun xx.
J Clin Invest. 2020 Jan 2;130(1):231-246. doi: 10.1172/JCI126390.
J Clin Invest. 2020.
PMID: 31763993
Free PMC article.